Search Results - "R. A. Khamitov"

Refine Results
  1. 1

    Optimization of genetic constructs for high-level expression of the darbepoetin gene in mammalian cells by Shukurov, R. R, Kazachenko, K. Yu, Kozlov, D. G, Nurbakov, A. A, Sautkina, E. N, Khamitov, R. A, Seryogin, Yu. A

    Published in Applied biochemistry and microbiology (01-12-2014)
    “…Genetic constructs were designed in order to optimize darbepoetin production in CHO cells. They are characterized by a higher level of structural optimization…”
    Get full text
    Journal Article
  2. 2

    Design of a stable cell line producing recombinant darbepoetin alpha based on CHO cells by Shukurov, R. R, Lobanova, N. V, Savinova, I. N, Vorobyova, I. G, Nurbakov, A. A, Ermolina, L. V, Orlova, N. V, Mosina, A. G, Antonova, L. P, Khamitov, R. A, Seryogin, Yu. A

    Published in Applied biochemistry and microbiology (01-12-2014)
    “…A stable cell line that is based on CHO cells and produces 100 mg per liter of culture medium of recombinant darbepoetin alpha with a target glycosylated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Methodological Approaches to Validation of Therapeutic Recombinant Proteins Production Based on the Quality by Design Concept by Stratonova, N. V., Lisov, A. S., Morozov, A. N., Tyupa, D. V., Khamitov, R. A.

    Published in Biopreparaty (28-09-2018)
    “…Validation of production processes based on the Quality by Design (QbD) principles calls for thorough scientific understanding of the processes and enhancement…”
    Get full text
    Journal Article Magazine Article
  5. 5

    The current pattern of reconstructive surgery for breast cancer by Ismagilov, A. Kh, Khamitov, A. R., Vanesyan, A. S.

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (01-11-2015)
    “…In Russia, breast cancer (BC) occupies a leading place in the pattern of cancers, the incidence of which is 20.9 %, among the female population; in 2013 there…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antiviral effectiveness of the combined use of amixine and virasole in experimental hemorrhagic fever with renal syndrome in sucking albino mice by Loginova, S Ia, Koval'chuk, A V, Borisevich, S V, Kopylova, N K, Pashchenko, Iu I, Khamitov, R A, Maksimov, V A, Shuster, A M

    Published in Voprosy virusologiĭ (01-11-2005)
    “…The antiviral effectiveness of the combined and single use of superlow-dose amixine and virasole on the course of experimental hemorrhagic fever with renal…”
    Get more information
    Journal Article
  8. 8

    Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome by S. Ya. Loginova, V. N. Shchukina, S. V. Borisevich, R. A. Khamitov, V. A. Maksimov, A. M. Shuster

    “…Studies have been conducted to assess the effectiveness of Arbidol® in relation to the experimental form of severe acute respiratory syndrome in Syrian Golden…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Plastic surgery for breast cancer: еssentials, classification, performance algorithm by A. Kh. Ismagilov, A. S. Vanesyan, A. R. Khamitov, I. F. Kamaletdinov

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (01-01-2015)
    “…The choice of plastic surgical techniques for cancer is influenced by two factors: resection volume/baseline breast volume ratio and tumor site.Based on these…”
    Get full text
    Journal Article
  12. 12

    Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection by Zuev, E. V., Evdokimova, O. L., Markova, O. A., Korotkevich, I. A., Grigorieva, T. V., Khamitov, R. A.

    Published in Biopreparaty (01-10-2023)
    “…Scientific relevance. Intranasal vaccination may dramatically change current approaches to mass immunisation against various infections, shifting the focus…”
    Get full text
    Magazine Article
  13. 13

    An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic by Morozov, A. N., Yakhin, I. R., Stratonova, N. V., Kutskir, M. V., Poteryaev, D. A., Khamitov, R. A.

    Published in Biopreparaty (01-12-2022)
    “…The COVID-19 pandemic has presented a global challenge to the health system. More than 200 years of world epidemiological experience since the first mass use…”
    Get full text
    Magazine Article
  14. 14

    Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19 by Poteryaev, D. A., Khamitov, R. A., Efimov, G. A., Shuster, A. M.

    Published in Biopreparaty (18-09-2020)
    “…Determination of T-cell immune response to SARS-CoV-2 is important both for diagnosis of the disease in symptomatic patients, and for determination of the…”
    Get full text
    Magazine Article
  15. 15

    Validation of a test procedure for determination of specific activity of human recombinant interferon beta (Infibeta®) using various cell/virus combinations by Lebedeva, Yu. N., Litvinova, N. A., Lobanova, T. N., Shukurov, R. R., Khamitov, R. A., Gaiderova, L. A.

    Published in Biopreparaty (01-04-2022)
    “…Interferon beta preparations have demonstrated efficacy in the treatment of multiple sclerosis. One of the most important quality attributes that support…”
    Get full text
    Magazine Article
  16. 16

    Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit by Poteryaev, D. A., Abbasova, S. G., Ignatyeva, P. E., Strizhakova, O. M., Kolesnik, S. V., Khamitov, R. A.

    Published in Biopreparaty (02-10-2021)
    “…With the onset of the COVID-19 pandemic, a number of molecular-based tests have been developed to diagnose SARS-CoV-2 infection. However, numerous available…”
    Get full text
    Magazine Article
  17. 17

    The Creation of Technological Lines for the Cultivation of Modified Lines of Mammalian Cells Expressing Recombinant Proteins by I. A. Churkin, S. V. Borisevich, D. A. Kutaev, V. T. Lymar, Yu. I. Pashchenko, E. V. Gordeev, V. S. Kulish, T. M. Plekhanova, R. A. Khamitov, E. N. Sautkina

    “…The article presents data for creating technological line for the cultivation of modified lines of mammalian cells expressing recombinant proteins. This line…”
    Get full text
    Journal Article
  18. 18

    Optimisation of culture conditions for a producer clone coexpressing arylsulfatase B and a formylglycine-generating enzyme in order to increase the yield of arylsulfatase B by Timonova, S. S., Smolova, K. A., Kirik, I. A., Pantyushenko, M. S., Anisimov, R. L., Khamitov, R. A., Piskunov, A. A., Bade, V. N.

    Published in Biopreparaty (10-10-2022)
    “…Maroteaux—Lamy syndrome (mucopolysaccharidosis type VI) is an orphan genetic disease caused by mutations in the arylsulfatase B gene ( ARSB ), which encodes…”
    Get full text
    Magazine Article
  19. 19

    Increasing productivity of arylsulfatase B-producing cell line by coexpression of formylglycine-generating enzyme by Timonova, S. S., Smolova, K. A., Zaripova, D. T., Pantyushenko, M. S., Koroleva, M. A., Anisimov, R. L., Khamitov, R. A., Piskunov, A. A., Bade, V. N.

    Published in Biopreparaty (09-04-2022)
    “…Mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome) is an orphan genetic disease caused by deficiency of the lysosomal enzyme arylsulfatase B (ASB). The…”
    Get full text
    Magazine Article
  20. 20

    Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products by Gusarova, V. D., Pantyushenko, M. S., Simonov, V. M., Shukurov, R. R., Khamitov, R. A., Vishnevskiy, A. Yu

    Published in Biopreparaty (25-03-2019)
    “…Recombinant tissue plasminogen activator (international nonproprietary name — alteplase) which was developed by «GENERIUM» (Russia) and received a marketing…”
    Get full text
    Magazine Article